Jack Kaye

CIK 1376099 · last filed 2026-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$772.1K

Companies

3

Total Filings

49

Lifetime Open-Market Net

-$1.94M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QURE Director 25,996 $27.57 $716.7K -$1.75M 22 2026-06-12
DYAI Director 81,201 $0.68 $55.4K $0 10 2026-01-06
KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Director 86,400 -$195.8K 17 2015-06-18

Recent Filings · Page 3 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-03-04 QURE Sell (S) −504 -$19.0K EDGAR
2021-03-01 QURE Grant (A) +2,382 $0 EDGAR
2021-01-06 DYAI Grant (A) $0 EDGAR
2020-03-02 QURE Grant (A) +2,063 $0 EDGAR
2020-01-30 QURE Sell (S) −806 -$50.1K EDGAR
2020-01-03 DYAI Grant (A) $0 EDGAR
2019-06-27 DYAI Grant (A) $0 EDGAR
2019-01-31 QURE Grant (A) +3,230 $0 EDGAR
2019-01-31 QURE Sell (S) −1,210 -$37.9K EDGAR
2018-01-31 QURE Sell (S) −2,878 -$53.3K EDGAR
Showing 2130 of 49
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.